Related Experiment Video
Updated: May 15, 2025

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes
Published on: March 19, 2019
Plant-made trained immunity-based vaccines: Beyond one approach
Elizabeth Monreal-Escalante1, Miriam Angulo2, Abel Ramos-Vega3
1Immunology & Vaccinology Group and Laboratorio Nacional CONAHCYT (SECIHTI) de Generación de Vacunas Veterinarias y Servicios de Diagnóstico (LNC-GVD). Centro de Investigaciones Biológicas del Noroeste, S.C. Instituto Politécnico Nacional 195, Playa Palo de Santa Rita Sur, La Paz, B.C.S. 23096, Mexico; SECIHTI-Centro de Investigaciones Biológicas del Noroeste, S.C. Instituto Politécnico Nacional 195, Playa Palo de Santa Rita Sur, La Paz, B.C.S. 23096, Mexico.
Plant-made vaccines offer cost-effective production, while trained immunity-based vaccines (TIbV) induce broad innate immune memory. This review explores their potential synergy for enhanced disease protection, addressing current limitations for future vaccine development.
Area of Science:
- Vaccinology
- Immunology
- Biotechnology
Background:
- Plant-made vaccines offer a scalable and economical platform for vaccine production.
- Trained immunity-based vaccines (TIbV) leverage innate immune memory for broad protection against various pathogens.
- Current research has not integrated these two promising vaccine strategies in a transdisciplinary approach.
Purpose of the Study:
- To review the fundamental knowledge and practical applications of plant-made vaccines and TIbV.
- To identify limitations hindering the widespread adoption of each vaccine strategy.
- To explore the potential for a unified approach combining plant-made vaccines with TIbV.
Main Methods:
- Literature review of existing research on plant-made vaccines.
- Literature review of existing research on trained immunity-based vaccines (TIbV).
- Analysis of experimental examples and practical applications of both strategies.
Main Results:
- Plant-based vaccine production is cost-efficient and scalable.
- TIbV demonstrates potential for broad-spectrum protection through innate immune memory.
- Significant limitations exist for both strategies, hindering widespread clinical application.
Conclusions:
- Plant-made vaccines and TIbV are compatible strategies with potential for synergy.
- A transdisciplinary approach is needed to overcome current limitations.
- Future research on plant-made TIbV could offer novel solutions for global health challenges.
More Related Videos
05:33Author Spotlight: Optimizing Apoplast Protein Extraction for Efficient Recovery of Recombinant Proteins from Plant Cells
Published on: July 5, 2024
00:10Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Tumor Immunotherapy
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...